Reflections on the era of valvular intervention—The perspective of surgeons
10.7507/1007-4848.202107094
- VernacularTitle:瓣膜介入时代的思考—外科医生视角
- Author:
Yunlong WU
1
;
Yin WANG
1
;
Nianguo DONG
1
Author Information
1. Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P.R.China
- Publication Type:Journal Article
- Keywords:
Heart valve diseases;
interventional therapy;
transcatheter aortic valve replacement (TAVR);
surgical aortic valve replacement (SAVR)
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2021;28(12):1415-1419
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, the number of interventions for valvular heart disease has been increasing day by day, and it has become a hot topic in the field of cardiovascular surgery. Given the aging global population and trends in the prevalence of valvular disease and the broadening of indications for transcatheter aortic valve replacement (TAVR), a breakthrough of 130 000 TAVR procedures is expected by 2026. In the new technology development period, the development potential and technical advantages of heart valve interventional therapy should be faced squarely. This paper focuses on key issues such as comparison of outcomes after TAVR versus surgical aortic valve replacement (SAVR), prosthetic valve endocarditis after TAVR, and broadening of indications for TAVR, as well as recommendations on how surgeons face the era of TAVR. We hope that this article will help and attract the attention of cardiac surgeons.
